
Blood Test Predicts Dementia Risk 25 Years Early
Scientists developed a simple blood test that can predict dementia risk in women up to 25 years before symptoms appear. The breakthrough could help doctors start prevention strategies decades earlier than ever before.
Imagine knowing your dementia risk a quarter century before any memory problems begin. That future just got closer thanks to researchers at UC San Diego.
Scientists analyzed blood samples from nearly 3,000 women over 65 who showed no signs of cognitive decline. After tracking them for up to 25 years, they discovered something remarkable.
A specific protein called p-tau217 strongly predicted who would develop dementia decades later. Women with higher levels of this biomarker at the study's start were much more likely to develop the disease.
The test works through a simple blood draw, making it far more accessible than current methods. Traditional detection requires brain imaging or spinal fluid tests, which are invasive and expensive.
"This suggests it may be possible to detect risk of dementia two decades in advance using a simple blood test," said lead researcher Dr. Aladdin Shadyab. The findings appeared today in JAMA Network Open.

The long lead time opens exciting possibilities. Doctors could start prevention strategies when they might actually make a difference, rather than waiting until memory problems already affect daily life.
The protein wasn't equally predictive for everyone. Women over 70 with higher p-tau217 levels showed worse outcomes than younger participants. Those with a known Alzheimer's risk gene also faced higher dementia rates.
Interestingly, the biomarker proved strongest in women receiving hormone therapy compared to those taking a placebo. This discovery could help personalize treatment approaches.
Why This Inspires
This research represents hope for millions of families touched by dementia. Early detection means early action, and early action could mean keeping loved ones sharp and independent for years longer.
The test isn't ready for your doctor's office yet. Researchers emphasize more studies are needed, especially in men and younger populations. But the foundation is solid.
Blood biomarkers like p-tau217 could accelerate research into what actually causes dementia and which strategies truly reduce risk. That knowledge could transform how we approach brain health as we age.
For now, this breakthrough proves we're getting closer to outsmarting a disease that has devastated too many families for too long.
More Images




Based on reporting by Fox News Health
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it


